Skip Navigation
Newsroom

Company news

Business
22 September 2020

Alvotech and DKSH extend partnership in Asia

Alvotech and DKSH, a leading healthcare provider across 36 emerging countries in South-East Asia, today announced an expansion of their strategic partnership to commercialize six new biosimilar product candidates for the Asian markets.

Business
05 August 2020

Alvotech and Teva announce strategic partnership to collaborate in the U.S. biosimilar market

Tanya Zharov
People
18 May 2020

Tanya Zharov joins Alvotech as Deputy CEO

Business
12 May 2020

Alvotech announces positive top-line results for two comparative studies for AVT02, a proposed biosimilar to HUMIRA® (adalimumab)

Business
05 May 2020

Alvotech and Alvogen launch new B2B business brand

Business
24 March 2020

Delivering on our promise during the Coronavirus Pandemic

Business
24 March 2020

Alvotech and DKSH partner to bring key biosimilar to Asia

Business
14 January 2020

Alvotech and JAMP Pharma enter into an exclusive partnership for the commercialization of key biosimilars in Canada

Business
13 November 2019

Alvotech at CPhI 2019

Peter Goldschmidt, Robert Wessman, Mark Levick
Business
06 November 2019

Alvotech and Stada agree on strategic biosimilar partnership

Business
04 November 2019

Yas Holding invests in Alvotech and agrees on a strategic partnership for biosimilar candidates

People
30 September 2019

Alvotech appoints new Chief Scientific Officer

Business
13 September 2019

Alvotech is warming up for CPhI 2019 in Frankfurt

Business
27 August 2019

Alvotech and Prestige Biopharma announce new manufacturing partnership

Business
29 July 2019

Alvotech and Cipla gulf into a partnership

Business
15 July 2019

Alvotech completes enrollment of phase III study involving biosimilar version of Humira®

Business
03 June 2019

Alvotech and Abdi Ibrahim enter into an exclusive partnership

People
09 May 2019

Mark Levick appointed CEO of Alvotech

Business
09 April 2019

Alvotech and Fuji Pharma announce agreement

Media Contact

Halldor Kristmannsson

Corporate Marketing & Communication

Phone (354) 522-2900